Figure 2.
The levels of three exosomal lncRNAs in NSCLC patients in the validation set. (A) qRT-PCR analysis of three exosomal lncRNAs in NSCLC patients, stage I NSCLC patients and healthy controls. (B) qRT-PCR analysis of three exosomal lncRNAs in lung ADC patients, SCC patients and healthy controls (n=100). * p < 0.05, ** p < 0.01, *** p < 0.001. n.s, no signification, p > 0.05.